These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37364296)

  • 1. The primary cardiomyopathy of systemic sclerosis on cardiovascular magnetic resonance imaging.
    Chhikara S; Kanda A; Ogugua FM; Rouf R; Nouraee C; Bawaskar P; Molitor JA; Shenoy C
    Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):1661-1671. PubMed ID: 37364296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis.
    Feher A; Miller EJ; Peters DC; Mojibian HR; Sinusas AJ; Hinchcliff M; Baldassarre LA
    Rheumatol Int; 2023 May; 43(5):849-858. PubMed ID: 36894756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac magnetic resonance imaging T1 mapping and late gadolinium enhancement entropy: Prognostic value in patients with systemic sclerosis.
    Yamamoto A; Nagao M; Shirai Y; Nakao R; Sakai A; Kaneko K; Arashi H; Minami Y; Sakai S; Yamaguchi J
    J Cardiol; 2023 Nov; 82(5):343-348. PubMed ID: 37031795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis.
    Krumm P; Mueller KA; Klingel K; Kramer U; Horger MS; Zitzelsberger T; Kandolf R; Gawaz M; Nikolaou K; Klumpp BD; Henes JC
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):70. PubMed ID: 27765061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
    Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
    Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
    Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
    Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients.
    Infante AN; Koo CCY; Yip A; Lim YH; Yeo WT; Quek ST; Lim TW; Seow SC; Chai P; Ong CC; Teo L; Singh D; Kojodjojo P
    Singapore Med J; 2021 Jul; 62(7):347-352. PubMed ID: 31820004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
    Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
    Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis.
    Butcher SC; Vos JL; Fortuni F; Galloo X; Liem SIE; Bax JJ; Delgado V; Vonk MC; van Leuven SI; Snoeren M; El Messaoudi S; de Vries-Bouwstra JK; Nijveldt R; Ajmone Marsan N
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI20-SI31. PubMed ID: 35482539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.
    Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM
    J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
    Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.
    Bai W; Xu R; Li X; Xu H; Fu H; Hou R; Zhou Z; Huang W; Wang Y; Guo Y
    BMC Cardiovasc Disord; 2022 Dec; 22(1):526. PubMed ID: 36474142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.